AT1R gene rs389566 polymorphism contributes to MACCEs in hypertension patients
暂无分享,去创建一个
Fen Liu | Yining Yang | Xiao-Ming Gao | Xiaomei Li | B. Fang | G. Du | Tong Zhang | Jun-Yi Luo | Yang-Min Hao
[1] Beata Franczyk,et al. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease , 2022, Biomedicines.
[2] M. Barreto-Chaves,et al. Beta-arrestins in the context of cardiovascular diseases: Focusing on type 1 angiotensin II receptor (AT1R). , 2022, Cellular signalling.
[3] Mickael S. Luz,et al. Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7 , 2020, Frontiers in Physiology.
[4] M. Alberts,et al. Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors , 2020, Journal of the American Heart Association.
[5] Sergio Lavandero,et al. Counter-regulatory renin–angiotensin system in cardiovascular disease , 2019, Nature Reviews Cardiology.
[6] B. Lampert,et al. Hypertension and Heart Failure. , 2019, Heart failure clinics.
[7] Hung-Fat Tse,et al. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[8] Yanxian Lai,et al. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus , 2018, Cardiovascular Diabetology.
[9] P. Damman,et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group , 2018, Netherlands Heart Journal.
[10] G. Mancia,et al. Treatment of hypertension: The ESH/ESC guidelines recommendations. , 2017, Pharmacological research.
[11] Xiang Ma,et al. Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China , 2017, PloS one.
[12] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[13] K. Kalantar-Zadeh,et al. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. , 2016, Journal of the American College of Cardiology.
[14] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[15] Alejandro Lucia,et al. Epidemiology of coronary heart disease and acute coronary syndrome. , 2016, Annals of translational medicine.
[16] M. Gai,et al. [Current status regarding the cardiovascular disease-related risk levels among the hypertensive population of different ethnicities in Xinjiang Uygur Autonomous Region, China]. , 2016, Zhonghua yi xue za zhi.
[17] K. Reynolds,et al. Visit-to-Visit Variability of Blood Pressure and Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis , 2014, Hypertension.
[18] Hua-Fu Zhou,et al. A systematic review and meta-analysis of the association between angiotensin II type 1 receptor A1166C gene polymorphism and myocardial infarction susceptibility , 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[19] G. Mancia. The New American Guidelines on Hypertension: A Favorable Opinion , 2014, Journal of clinical hypertension.
[20] W. Niu,et al. Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polymorphism and coronary artery disease in Chinese populations , 2013, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[21] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[22] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[23] Li-sheng Liu,et al. [2010 Chinese guidelines for the management of hypertension]. , 2011, Zhonghua xin xue guan bing za zhi.
[24] H. Zhang,et al. Association of the angiotensin type 1 receptor gene A1166C polymorphisms with myocardial infarction: a meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.
[25] Xiang Ma,et al. [Prevalence of peripheral arterial disease and its correlative risk factors in Xinjiang Uygur and Kazak adult populations]. , 2010, Zhonghua yi xue za zhi.
[26] Xiang Ma,et al. [Incidence and distributing feature of chronic heart failure in adult population of Xinjiang]. , 2010, Zhonghua xin xue guan bing za zhi.
[27] Dingquan Yang,et al. Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type , 2009, Chinese journal of integrative medicine.
[28] Jiunn-lee Lin,et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure , 2009, Journal of hypertension.
[29] Rajesh Kumar,et al. The intracellular renin–angiotensin system: implications in cardiovascular remodeling , 2008, Current opinion in nephrology and hypertension.
[30] N. Dali-Youcef,et al. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Fredman,et al. Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older. , 1999, Preventive medicine.
[32] P. Amouyel,et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. , 1997, Journal of the American College of Cardiology.
[33] P Ducimetière,et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.
[34] L. Tiret,et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.
[35] Chi‐Hang Lee,et al. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study. , 2016, Atherosclerosis.
[36] M. Litwin,et al. Guidelines for the Management of Hypertension , 2015 .
[37] Ran Jin-ju. Meta-analysis on the risks factors of coronary heart diease , 2014 .
[38] L. Tiret,et al. hypertension Angiotensin II type 1 receptor gene polymorphisms in human essential , 2009 .
[39] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[40] Li Yunqian. Comparison of coronary angiography and three kinds of noninvasive methods in the diagnosis of coronary artery disease , 1999 .
[41] R. Collins,et al. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.